Oviva Therapeutics, a Cambrian BioPharma *PipeCo, announces Seed Financing and Exclusive License with Massachusetts General Hospital to Develop Therapeutics to Extend Healthspan in Women

/PRNewswire/ -- Oviva Therapeutics, Inc. (Oviva), the women's health biotech company and a Cambrian Biopharma *PipeCo, today announced an in-licensing...

Related Keywords

Harvard University ,Massachusetts ,United States ,Daisy Robinton ,Patriciak Donahoe ,Biopharma Pipeco ,Rosa Argyropoulos ,James Peyer ,Linkedin ,A Distributed Development Company Or Disco ,Pediatric Surgical Research Laboratories ,Women Health ,Cambrian Biopharma Inc ,Professor At Harvard Medical School ,Oviva Therapeutics Inc ,Emerita Of Pediatric Surgical Services ,Prnewswire Oviva Therapeutics Inc ,Oviva As Co ,Professor Of Surgery At Harvard Medical School ,General Hospital ,Cambrian Biopharma ,Massachusetts General Hospital ,Chief Emerita ,Pediatric Surgical Services ,Tenured Professor ,Harvard Medical School ,Associate Molecular Biologist ,Associate Professor ,Harvard Medical ,Biopharma Inc ,Distributed Development Company ,Oviva Therapeutics ,